In NSCLC tumorigenesis, the oncogenes promote NSCLC progression by acting as a suppressor of ferroptosis, independent of SLC7A11, GPX4 or NRF2 [7]. The gene discussed is GPX4; the disease is non-small cell lung carcinoma.